News & Analysis on Clinical Trial Services & Contract Research And Development
CHDI and Edison Pharmaceuticals have entered into alliance that looks to develop effective therapeutics in targeting Huntingdon's disease - a disorder that currently has no way to stop or reverse the its progression.
Nektar Therapeutics has closed its processing plant in Bradford, UK as it shifts its focus to developing its own drug products using its own drug delivery technology.
The Food and Drug Administration (FDA) will beef up its process for disclosing the conflicts of interest of its advisory experts in a bid to restore its reputation after a survey suggests its scientists may be too closely tied with the drug industry...
UK government legislation designed to curb animal extremism appears to be working as statistics published this week records a reduction in the number of incidents provoked by animal rights extremists during the first half of this year.
Predix Phamaceuticals has formed a collaboration with Amgen in a deal that aims to develop S1P1 modulators for the treatment of autoimmune diseases. The agreement has the potential to become a $300m (€235m) payout for Predix.
Even with the most advanced analytical equipment, elucidating the complete conformational characteristics of proteins still represents mission impossible, often making their formulation problematic, yet there are always ways to improve their...
Chimatica makes available its range of pre-selected, target-specific screening compounds that provide new chemotypes and opportunities for accelerated lead identification and further optimisation.